Since antifungal therapy ameliorates colitis in Clec7a knockout mice and CLEC7A is associated with the severity of UC in humans, the role of this receptor in patients with non-IgE CMA may play a role in protecting against fungal-induced intestinal inflammation.73 The gene discussed is CLEC7A; the disease is colitis.